Sharmin Arif et al. 2023. HER2/neu over Expression: A Prognostic Marker and a Possible Therapeutic Target in Ovarian Carcinoma- An Outlook for the Future. Novel Research Aspects in Medicine and Medical Science Vol. 2. (Sep. 2023), 20–36. DOI:https://doi.org/10.9734/bpi/nramms/v2/10782F.